WHO ICTRP trial
Instrumental and clinical effects of withdrawal of beta blockers therapy in…
EUCTR2011-000890-29-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2011-000890-29-IT |
|---|---|
| Public title | Instrumental and clinical effects of withdrawal of beta blockers therapy in patients with heart failure and right ventricular dysfunction'' - Destro |
| Scientific title | Instrumental and clinical effects of withdrawal of beta blockers therapy in patients with heart failure and right ventricular dysfunction'' - Destro |
| Primary sponsor | FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | heart failure MedDRA version: 14.1 Level: LLT Classification code 10011949 Term: Decompensation cardiac System Organ Class: 10007541 - Cardiac disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Pharmaceutical Form: Tablet INN or Proposed INN: Carvedilol Concentration unit: mg milligram(s) Concentration number: 25- Pharmaceutical Form: Tablet INN or Proposed INN: Nebivolol Concentration unit: mg milligram(s) Concentration number… |
| Registration date | Mar 13, 2012 |
| Secondary IDs | Destro |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: